Evidence map›Paper›PMID 37835425›Full record

ArticleCancers2023

Comparing Robotic-Assisted to Open Radical Cystectomy in the Management of Non-Muscle-Invasive Bladder Cancer: A Propensity Score Matched-Pair Analysis.

Etienne Courboin, Romain Mathieu, Valentina Panetta, Georges Mjaess, Romain Diamand, Gregory Verhoest, Mathieu Roumiguié, Anne Sophie Bajeot, Francesco Soria, Chiara Lonati and 22 more

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Cancers, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
1.3field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 4 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

32 authors at 16 institutions in 9 countries.

Etienne CourboinDepartment of Urology, University Clinics of Brussels, Hôpital Erasme, Université Libre de Bruxelles, 1070 Brussels, Belgium.
Romain MathieuDepartment of Urology, CHU Rennes, 35000 Rennes, France.
Valentina PanettaL'altrastatistica S.R.L., Consultancy & Training, Biostatistics Office, 00100 Rome, Italy.ORCID 0000-0001-6058-5045
Georges MjaessDepartment of Urology, University Clinics of Brussels, Hôpital Erasme, Université Libre de Bruxelles, 1070 Brussels, Belgium.ORCID 0000-0002-8703-4611
Romain DiamandDepartment of Urology, Institut Jules Bordet, Université Libre de Bruxelles, 1070 Brussels, Belgium.ORCID 0000-0002-2016-8543
Gregory VerhoestDepartment of Urology, CHU Rennes, 35000 Rennes, France.
Mathieu RoumiguiéDepartment of Urology, Andrology and Renal Transplantation, CHU Rangueil, Paul-Sabatier University, 31000 Toulouse, France.ORCID 0000-0002-2412-146X
Anne Sophie BajeotDepartment of Urology, Andrology and Renal Transplantation, CHU Rangueil, Paul-Sabatier University, 31000 Toulouse, France.
Francesco SoriaDivision of Urology, Department of Surgical Sciences, San Giovanni Battista Hospital, University of Studies of Torino, 10024 Turin, Italy.
Chiara LonatiDepartment of Urology, Spedali Civili di Brescia, 25123 Brescia, Italy.ORCID 0000-0003-0113-9920
Claudio SimeoneDepartment of Urology, Spedali Civili di Brescia, 25123 Brescia, Italy.
Giuseppe SimoneDepartment of Urology, Regina Elena National Cancer Institute, 00100 Rome, Italy.ORCID 0000-0002-4868-9025
Umberto AnceschiDepartment of Urology, Regina Elena National Cancer Institute, 00100 Rome, Italy.
Paolo UmariDepartement of Urology, Ospedale Maggiore della Caritá di Novara, Universitá del Piemonte Orientale, 28100 Novarra, Italy.ORCID 0000-0001-7025-1559
Ashwin SridharDivision of Surgery and Interventional Sciences, University College London, London WC1E 6BT, UK.ORCID 0000-0001-8070-4822
John KellyDivision of Surgery and Interventional Sciences, University College London, London WC1E 6BT, UK.
Laura S MertensDepartment of Urology, Netherlands Cancer Institute, 1066 CX Amsterdam, The Netherlands.
Rafael Sanchez-SalasDepartment of Urology, Institut Mutualiste Montsouris, 70123 Paris, France.
Anna ColomerDepartment of Urology, Institut Mutualiste Montsouris, 70123 Paris, France.
Maria Angela CerrutoDepartment of Urology, University of Verona, Azienda Ospedaliera Universitaria Integrata, 37100 Verona, Italy.
Alessandro AntonelliDepartment of Urology, University of Verona, Azienda Ospedaliera Universitaria Integrata, 37100 Verona, Italy.
Wojciech KrajewskiDepartment of Minimally Invasive and Robotic Urology, Wrocław Medical University, 50-556 Wroclaw, Poland.
Thierry QuackelsDepartment of Urology, University Clinics of Brussels, Hôpital Erasme, Université Libre de Bruxelles, 1070 Brussels, Belgium.
Alexandre PeltierDepartment of Urology, Institut Jules Bordet, Université Libre de Bruxelles, 1070 Brussels, Belgium.
Francesco MontorsiUnit of Urology, Urological Research Institute, IRCCS Ospedale San Raffaele, 20132 Milan, Italy.
Alberto BrigantiUnit of Urology, Urological Research Institute, IRCCS Ospedale San Raffaele, 20132 Milan, Italy.
Jeremy Y C TeohS.H. Ho Urology Centre, Department of Surgery, Prince of Wales Hospital, The Chinese University of Hong Kong, Hong Kong, China.ORCID 0000-0002-9361-2342
Benjamin PradereDepartment of Urology, University of Vienna, 1010 Vienna, Austria.ORCID 0000-0002-7768-8558
Marco MoschiniUnit of Urology, Urological Research Institute, IRCCS Ospedale San Raffaele, 20132 Milan, Italy.
Thierry RoumeguèreDepartment of Urology, University Clinics of Brussels, Hôpital Erasme, Université Libre de Bruxelles, 1070 Brussels, Belgium.ORCID 0000-0002-5377-8137
Simone AlbisinniDepartment of Urology, University Clinics of Brussels, Hôpital Erasme, Université Libre de Bruxelles, 1070 Brussels, Belgium.
European Association of Urology-Young Academic Urologists (EAU-YAU), Urothelial Carcinoma Working Group
Université Libre de Bruxelles · BEIRCCS Ospedale San Raffaele · ITAzienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia · ITCentre Hospitalier Universitaire de Rennes · FRInstitute Mutualiste Montsouris · FRUniversité Toulouse III - Paul Sabatier · FRUniversity College London · GBUniversity of Verona · ITAzienda Ospedaliero Universitaria San Giovanni Battista · ITChinese University of Hong Kong · HKData Management (Italy) · ITThe Netherlands Cancer Institute · NLUniversità degli Studi del Piemonte Orientale “Amedeo Avogadro” · ITUniversity of Rome Tor Vergata · ITUniversity of Vienna · ATWroclaw Medical University · PL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundFor non-muscle-invasive bladder cancer (NMIBC) requiring radical surgery, limited data are available comparing robotic-assisted radical cystectomy with intracorporeal urinary diversion (iRARC) to open radical cystectomy (ORC). The objective of this study was to compare the two surgical techniques.

methodsA multicentric cohort of 593 patients with NMIBC undergoing iRARC or ORC between 2015 and 2020 was prospectively gathered. Perioperative and pathologic outcomes were compared.

resultsA total of 143 patients operated on via iRARC were matched to 143 ORC patients. Operative time was longer in the iRARC group (

conclusionWe found that iRARC for patients with NMIBC is safe, associated with a lower blood loss, a lower transfusion rate and a shorter hospital stay compared to ORC. Complication rates were similar. No significant differences in survival analyses emerged across the two techniques.

Indexed as

cystectomyintracorporeal urinary diversionnon-muscle-invasive bladder canceropen radical cystectomyrobotic-assisted radical cystectomy

Identifiers

PMID37835425
PMCPMC10571883
OpenAlexW4387048618

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.